Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Moving with the Times for        Better Drug Development                                           comes to finding ways t...
The Pharma Network – marcus                  About the Discovery Summit 2013  evans Summits group delivers  peer-to-peer  ...
Upcoming SlideShare
Loading in …5
×

Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma

466 views

Published on

Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma, a speaker at the marcus evans Discovery Summit 2013, on the importance of collaboration between the pharmaceutical industry and academia.

  • Be the first to comment

  • Be the first to like this

Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma

  1. 1. Moving with the Times for Better Drug Development comes to finding ways to implement and How can pharmaceutical models transfer new ideas through the better deliver to market? pharmaceutical process. Combining these two strengths increases The increasing cost of developing productivity and decreases the time compounds from idea to market is a needed for ideas to become tangible major issue at the moment. Firm drugs in the market. decisions must be made on whether to cease development of projects before What best practices provide true they become very expensive. This way medical value? costs can be better controlled and the outcome of clinical trials more positive. As the industry is proceeding into more of a collaboration mode, it is importantInterview with: Hasse Kromann, that scientists be able to work acrossHead of Section R&D Partnership culture groups, industries and barriers.Management, Innovation &Research, LEO Pharma They should come out from behind their desks and really look at patient needs. This will spark innovation and provide The industryDrug discovery can create truemedical value when scientists work them with the inspiration needed to come up with bright ideas for new should be adaptableacross cultural groups and focus on products that meet real-life needs.patient needs and problems, says HasseKromann, Head of Section R&D How can open innovation platforms and able toPartnership Management, Innovation & be designed to deliver compoundsResearch, LEO Pharma. “This will spark to the clinic in the future?innovation and provide them with theinspiration needed to come up withbright ideas for new products,” he adds. The industry is currently experimenting with different platforms and ways of collaborating with biotech and academic identifyA speaker at the marcus evansDiscovery Summit 2013, in Monte institutions to run fast exploratory clinical trials. which models work bestCarlo, Monaco, 21 - 22 March, Kromanndiscusses why proving concepts earlier When this is achieved, the discoveryon in drug development will save and clinical work will be bridged and in specificcosts. patients’ needs and problems can then take centre stage.Why is close cooperation betweenindustry and academia so importantto drug discovery? Different platforms will suit different clinical objectives. projectsThe pharmaceutical industry has theability to develop new drugs and The industry should be adaptable and able to identify which models work best or issuesacademia is very innovative when it for specific projects or issues.
  2. 2. The Pharma Network – marcus About the Discovery Summit 2013 evans Summits group delivers peer-to-peer information on This unique forum will take place at Le Méridien Beach Plaza, Monte Carlo, Monaco, strategic matters, professional 21 - 22 March, 2013. Offering much more than any conference, exhibition or trade trends and breakthrough show, this exclusive meeting will bring together esteemed industry thought leaders innovations. and solution providers to a highly focused and interactive networking event. The Summit includes presentations and interactive forums on building bridges from pre- clinical to clinical studies and designing open innovation platforms. www.discovery-summit.com Please note that the Summit is a closed business event and the Contact number of participants strictly limited. Maria Gregoriou, Journalist, marcus evans, Summits Division Tel: + 357 22 849 400 Email: press@marcusevanscy.com For more information please send an email to info@marcusevanscy.com All rights reserved. The above content may be republished or reproduced. Kindly inform us by sending an email to press@marcusevanscy.comAbout marcus evans Summitsmarcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discussstrategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity toindividually tailor their schedules of keynote presentations, think tanks, seminars and one-to-one business meetings.For more information, please visit: www.marcusevans.comUpcoming EventsEvolution Summit (North America) - www.evolutionsummit.comEvolution Summit (Europe) - www.evolution-summit.comTo view the web version of this interview, please click here: www.discovery-summit.com/HasseKromann

×